In Monday’s Opportunities in Review webinar, we highlighted MPL as a high conviction buy strategy. Our entry level was $2.75.
The price action this week suggests offshore fund managers have been aggressively buying Medibank.
You're not a member! Trial today
With a defensive 4.3% yield, the stock is attractive at current levels.
Medibank Private
